GERM ETFMG Treatments Testing and Advancements ETF
GERM Fund Description
GERM tracks a tier-weighted, narrow index of US-listed, global biotech companies that are engaged in the testing and treatments of infectious diseases.
GERM Factset Analytics Insight
GERM provides unique exposure to a subsector of biotech industry. The passively-managed fund holds companies that test and develop treatments against infectious diseases by focusing on companies at the forefront of R&D, vaccines, therapies and testing technologies. Companies included in the index must meet minimum market-cap and liquidity requirements. Also, companies must have an operating company structure, no pass-through securities. Selected stocks are weighted in tiers wherein the top five largest constituents receives 30% weight in the index in aggregate with an equal weight of 6% each, while the remaining securities are weighted by market-cap with 4% single security cap. Companies with market-cap of $15 billion or more are also equally weighted, receiving 10% portion of the portfolio in aggregate. The index is rebalanced and reconstituted every quarter.
GERM Summary Data
GERM Portfolio Data
GERM Index Data
GERM Portfolio Management
GERM Tax Exposures
GERM Fund Structure
GERM Factset Analytics Block Liquidity
This measurement shows how easy it is to trade a $1 million USD block of GERM. GERM is rated a 1 out of 5.
GERM Sector/Industry Breakdown
GERM Top 10 Holdings[View All]
GERM Economic Development
GERM Performance Statistics
GERM Benchmark Comparison Summary
GERM Benchmark Comparison Market Cap Size